Four months after Engel started taking Ozempic to treat his diabetes, he woke one morning unable to see out of his right eye. His ophthalmologist told him the damage was permanent but couldn’t explain what caused it. No one suggested Ozempic might be involved, so Engel kept taking the GLP-1 drug.
For millions of patients, GLP-1 drugs have been safe and effective, delivering important health benefits for those struggling with obesity, diabetes, heart disease and more. But with many millions of people taking the drugs, some uncommon problems are coming to light.
There is no evidence of a broad eye-safety problem with the use of GLP-1s, a counterpoint to the rare but serious issues like Engel’s. A 2026 study involving 5.5 million people found use of the drugs was associated with a lower incidence of macular degeneration. While the lack of evidence can’t prove the drugs are protective, it adds another layer of complexity to how people should think about them.
Put enough people on a drug and a side effect will appear. And then the press goes crazy.
ReplyDeleteMillions of complications of diabetes averted! Millions with sleep apnoea and fatty liver benefited. But a dozen people across North America had vision problems? Let's condemn the drug!
How many people are admitted to hospital every year with stomach bleeds from over-the-counter ibuprofen? No one talks about it. But when it's a fancy drug that is making a positive difference for millions? That's a class action suit waiting to happen.